Page last updated: 2024-10-29

whi p154 and Neoplasms

whi p154 has been researched along with Neoplasms in 1 studies

WHI P154: an anti-leukemic agent; structure in first source

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sudbeck, EA1
Ghosh, S1
Liu, XP1
Zheng, Y1
Myers, DE1
Uckun, FM1

Reviews

1 review available for whi p154 and Neoplasms

ArticleYear
Tyrosine kinase inhibitors against EGF receptor-positive malignancies.
    Methods in molecular biology (Clifton, N.J.), 2001, Volume: 166

    Topics: Adenocarcinoma; Amides; Aniline Compounds; Animals; Antineoplastic Agents; Breast Neoplasms; Drug De

2001